Sean Ellis - Jan 2, 2023 Form 4 Insider Report for Entera Bio Ltd. (ENTX)

Role
Director
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 2, 2023
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:05 PM
Previous filing
Nov 14, 2022
Next filing
Aug 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ENTX Stock Option (right to buy Award $0 +89K $0.00 89K Jan 2, 2023 Ordinary Shares, par value NIS 0.0000769 per share 89K $0.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest ratably on a quarterly basis over a one-year period that commenced on January 2, 2023.